US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

53.78

+0.86611.64%

Post-market: 53.940.1559+0.29%17:40 EDT

Volume:10K

Turnover:512.26K

Market Cap:51.09M

PE:- -

High:54.55

Open:54.51

Low:52.56

Close:52.91

52wk High:56.18

52wk Low:22.83

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.41

T/O Rate:1.01%

Dividend:0.65

Dividend Rate:1.21%

ROE:--

ROA:--

PB:1.16

PE(LYR):- -

Loading ...

Overview Company News Filings

Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo

Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints

10 Monday AM Reads

The Big Picture

High-Speed Rail Linking Ningbo and Suzhou Reaches New Milestone

White House Correspondents' Dinner Returns Amid Gunfire Shadow, Trump Steals the Spotlight: Considering a Fourth Term Bid

Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy

Organon to present results from analysis of Phase 3 trials of VTAMA cream

Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury

MacroGenics Advances MGC026 in Phase 1 Oncology Trial

Verastem doses first patient in TARGET-D 202 Phase 2 trial

Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results

Trump's $10 Billion Media Lawsuit Turns Toward His Own Business Empire as Judge Allows BBC to Examine Finances of More Than 400 Companies

Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market

Romesh Ranganathan makes it hard to defend the BBC

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update

10 Friday AM Reads

The Big Picture

UK Government Enacts Legislation to Nationalize British Steel, Controlled by China's Jingye Group; Chinese Ministry of Commerce Vows Strong Measures to Protect Chinese Firms

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BBC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":53.78,"timestamp":1788379200000,"preClose":52.9139,"halted":0,"volume":9603,"hourTrading":{"tag":"盘后","latestPrice":53.9359,"preClose":53.78,"latestTime":"17:40 EDT","volume":14,"amount":753.543602,"timestamp":1788385231057,"change":0.1559,"changeRate":0.002899,"amplitude":0.002899},"delay":0,"changeRate":0.016368099875458113,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Post-Mkt","change":0.8661,"latestTime":"09-02 18:25:17 EDT","open":54.51,"high":54.55,"low":52.56,"amount":512263.36349099997,"amplitude":0.037608,"askPrice":59.52,"askSize":100,"bidPrice":53.75,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788393600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":52.9139,"sharesOutstanding":900004,"nav":52.968,"aum":50319973.84,"dividendRate":0.012133,"bidAskSpread":0.002379,"postHourTrading":{"tag":"盘后","latestPrice":53.9359,"preClose":53.78,"latestTime":"17:40 EDT","volume":14,"amount":753.543602,"timestamp":1788385231057,"change":0.1559,"changeRate":0.002899,"amplitude":0.002899},"volumeRatio":0.411031,"impliedVol":0.3647,"impliedVolPercentile":0.7937},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.411031,"shares":950000,"dividePrice":0.6525,"high":54.55,"amplitude":0.037608,"preClose":52.9139,"low":52.56,"week52Low":22.825,"pbRate":"1.16","week52High":56.18,"institutionHeld":0,"latestPrice":53.78,"committee":0.333333,"eps":0,"divideRate":0.012133,"volume":9603,"delay":0,"ttmEps":0,"open":54.51,"prevYearClose":38.56,"prevWeekClose":53.2941,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":55.15,"twentyDayClose":51.193,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655839781","title":"Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2655839781","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655839781?lang=en_us&edition=fundamental","pubTime":"2026-07-29 07:59","pubTimestamp":1785283143,"startTime":"0","endTime":"0","summary":"Race Oncology Ltd. ( ($AU:RAC) ) has shared an announcement. Racura Oncology reported that the first patient in its HARNESS-1 Phase 1 trial has bee...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/racura-advances-harness-1-trial-after-safe-first-patient-treatment-with-rc220-combo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/racura-advances-harness-1-trial-after-safe-first-patient-treatment-with-rc220-combo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009645","title":"Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654009645?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:21","pubTimestamp":1785237677,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced topline results from C-BEYOND, its Phase 3 trial conducted in North America evaluating the once-daily fixed-d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","PSIL","BK4007","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045705","title":"10 Monday AM Reads","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045705","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045705?lang=en_us&edition=fundamental","pubTime":"2026-07-27 18:30","pubTimestamp":1785148206,"startTime":"0","endTime":"0","summary":"What Is Generation Jones And Why It’s Reshaping Succession Planning. Born between 1954 and 1964, now ages 62 to 72, disproportionately represented in CEO and board chair roles over much of the past decade. The term, coined by cultural commentator Jonathan Pontell, refers to a cohort that inherited the cultural promises made to early Boomers but entered adulthood in a more constrained economic era. Almost completely invisible in the generational workforce models guiding your talent strategy. This invisibility isn’t trivia. It’s a structural failure with consequences playing out in every organization right now. . Tesla’s robotaxis are moving in reverse: TechCrunch reports that Tesla’s autonomous driving program is losing ground — regulatory setbacks, safety incidents, and a technology gap that keeps widening as competitors pull ahead.  see also Robotaxis are the new millennial lifestyle subsidy: Sherwood argues the cheap-Uber era is back, with robotaxi VC underwriting the discount this t","market":"nz","thumbnail":"https://ritholtz.com/wp-content/uploads/2035/05/cryptohalf.jpg","type":0,"news_type":0,"thumbnails":["https://ritholtz.com/wp-content/uploads/2035/05/cryptohalf.jpg"],"rights":{"source":"ritholtz_highlight","url":"https://ritholtz.com/2026/07/10-monday-am-reads-485/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2026/07/10-monday-am-reads-485/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["IE00BMQBXF63.USD","BBC","IE00BZ18W456.USD","AM","BK4144","IE00BZ18W340.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148750116","title":"High-Speed Rail Linking Ningbo and Suzhou Reaches New Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=1148750116","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148750116?lang=en_us&edition=fundamental","pubTime":"2026-07-27 07:30","pubTimestamp":1785108638,"startTime":"0","endTime":"0","summary":"Ningbo to Suzhou: One-Hour Direct Connection AchievedThe Tongyu High-Speed Railway, a key infrastructure project, has reached a significant construction milestone. On July 26, the critical control...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196237935","title":"White House Correspondents' Dinner Returns Amid Gunfire Shadow, Trump Steals the Spotlight: Considering a Fourth Term Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=1196237935","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196237935?lang=en_us&edition=fundamental","pubTime":"2026-07-25 12:50","pubTimestamp":1784955055,"startTime":"0","endTime":"0","summary":"The White House Correspondents' Dinner resumed on July 24 local time, marking a \"fresh start\" following a shooting incident on April 25.While the organizers aimed to uphold tradition and avoid having...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036222","title":"Bristol-Myers Squibb Advances New Lung Cancer Combo Into Phase 2: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036222?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910898,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb is running a Phase 2 trial to test a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibb-advances-new-lung-cancer-combo-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0114720955.EUR","LU1093756168.USD","LU1868836757.USD","IE00BSNM7G36.USD","BK4585","BK4581","LU0321505439.SGD","LU2125154778.USD","BK4211","LU1093756325.SGD","BMY","BBC","LU1983299246.USD","LU2125154935.USD","LU0456855351.SGD","LU1585245621.USD","FTXH","LU1670710661.SGD","LU2242646821.SGD","LU1261432733.SGD","LU1868836914.USD","LU1291159041.SGD","LU0432979614.USD","LU1323610961.USD","LU0237698245.USD","LU1074936037.SGD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","BK4532","LU0225771236.USD","LU1868837136.USD","LU0267386448.USD","BK4007","LU0061475181.USD","LU0306807586.USD","PSIL","IHE","LU1670711040.USD","IE00B2B36J28.USD","LU1868836591.USD","ISBC","LU0985481810.HKD","BK4534","LU0882574055.USD","LU0306806265.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU0321505868.SGD","BK4588","LU1670710588.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654362520","title":"Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK","url":"https://stock-news.laohu8.com/highlight/detail?id=2654362520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654362520?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910878,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda is running a Phase 3 trial to test elritercept (TA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-elritercept-trial-targets-anemia-in-myelofibrosis-raising-long-term-upside-for-tak?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4007","TAK","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654036255","title":"Jazz Pharmaceuticals Advances Phase 3 Cannabidiol Trial in Severe Childhood Epilepsy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036255","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036255?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:33","pubTimestamp":1784910829,"startTime":"0","endTime":"0","summary":"Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is preparing a Phase 3 trial to test a new o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jazz-pharmaceuticals-advances-phase-3-cannabidiol-trial-in-severe-childhood-epilepsy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204084","title":"Organon to present results from analysis of Phase 3 trials of VTAMA cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204084?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895078,"startTime":"0","endTime":"0","summary":"Organon (OGN) will present results from a post hoc analysis of pooled data from the Phase 3 pivotal trials, ADORING 1 and ADORING 2, evaluating the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","FXH","LU2065169927.USD","LU2065171311.SGD","OGN","BK4585","BBC","BK4007","LU2065171402.SGD","LU2065170008.USD","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653708145","title":"Kringle Pharma Launches Additional Phase 3 Trial of Oremepermin Alfa in Acute Spinal Cord Injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2653708145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653708145?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:52","pubTimestamp":1784861536,"startTime":"0","endTime":"0","summary":"Kringle Pharma, Inc. ( ($JP:4884) ) has shared an announcement. Kringle Pharma has launched an additional Phase 3 trial in Japan to evaluate oremep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kringle-pharma-launches-additional-phase-3-trial-of-oremepermin-alfa-in-acute-spinal-cord-injury?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4135","JP","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653377631","title":"MacroGenics Advances MGC026 in Phase 1 Oncology Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653377631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653377631?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:33","pubTimestamp":1784838815,"startTime":"0","endTime":"0","summary":"MacroGenics ( ($MGNX) ) just unveiled an update. On July 23, 2026, MacroGenics reported a clinical update from its ongoing Phase 1 trial of MGC026,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/macrogenics-advances-mgc026-in-phase-1-oncology-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/macrogenics-advances-mgc026-in-phase-1-oncology-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653939797","title":"Verastem doses first patient in TARGET-D 202 Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653939797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653939797?lang=en_us&edition=fundamental","pubTime":"2026-07-23 04:06","pubTimestamp":1784750793,"startTime":"0","endTime":"0","summary":"Verastem (VSTM) Oncology announced that the first patient has been dosed in the TARGET-D 202 Phase 2 registration-directed trial evaluating VS-7375...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verastem-doses-first-patient-in-target-d-202-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PSIL","BBC","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653623367","title":"Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2653623367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653623367?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:01","pubTimestamp":1784739666,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals stock saw major gains after the company announced new results from a Phase 3 trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/arrowhead-pharmaceuticals-arwr-stock-soars-on-strong-phase-3-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BBC","ARWR","BK4585","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653756748","title":"Trump's $10 Billion Media Lawsuit Turns Toward His Own Business Empire as Judge Allows BBC to Examine Finances of More Than 400 Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2653756748","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653756748?lang=en_us&edition=fundamental","pubTime":"2026-07-22 15:52","pubTimestamp":1784706720,"startTime":"0","endTime":"0","summary":"Judge orders Trump to turn over financial records in lawsuit against BBC. Trump's team tried to avoid disclosure but had claim rejected.","market":"nz","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/07/22/London--Uk---August-23rd-2024-The-Bbc-Lo.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=3840,format=auto,quality=85/files/images/story/2026/07/22/London--Uk---August-23rd-2024-The-Bbc-Lo.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/politics/26/07/60599520/trumps-10-billion-media-lawsuit-turns-toward-his-own-business-empire-as-judge-allows-bbc-to-examine-finances-of-more-than-400-companies","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/politics/26/07/60599520/trumps-10-billion-media-lawsuit-turns-toward-his-own-business-empire-as-judge-allows-bbc-to-examine-finances-of-more-than-400-companies","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653171362","title":"Genmab’s Petosemtamab Trial Takes Aim at a Key Colorectal Cancer Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2653171362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653171362?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:31","pubTimestamp":1784565094,"startTime":"0","endTime":"0","summary":"Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has launched a Phase 3 trial testing petosemtamab plus chemotherap...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmabs-petosemtamab-trial-takes-aim-at-a-key-colorectal-cancer-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653131217","title":"Romesh Ranganathan makes it hard to defend the BBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2653131217","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653131217?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:17","pubTimestamp":1784564255,"startTime":"0","endTime":"0","summary":"The nearly four minute political broadcast on the nature of broadcast asks us to consider not what our BBC can do for us, but what we can do for our BBC. Romesh is whisked through a dizzying sweep of iconic TV locations – the Queen Vic, Graham Norton’s studio, the Strictly ballroom – as he repeats the central question in the dull, rhythmic style of a mid-ranking Labour minister.There are great cases to be made for the BBC. It projects British strength, creates tangible cultural moments, and knits together a framework of shared reality. But its own propaganda seems to miss all of this, and instead pummels the viewer with the grinning faces of its best-paid stars.Strictly and Traitors aside, not many BBC properties pull in viewers by the tens-of-millions anymore. As Romesh quips, “there are shows I wouldn’t dare to belittle,” he is duly chased by Daleks – part of the Doctor Who brand recently run into the ground by poorly-judged American financing and audience disinterest. So, it made se","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/romesh.ranganathan.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/romesh.ranganathan.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bbc-licence-fee-romesh-ranganathan-world-cup/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bbc-licence-fee-romesh-ranganathan-world-cup/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652840282","title":"GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2652840282","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652840282?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:32","pubTimestamp":1784305947,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The ALANIS study from GlaxoSmithKline (GSK) is a Phase 2 trial testing ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSK.UK","AL","BK4585","GSK","LU1169590202.USD","BK4007","IE0034390439.USD","LU1169589451.USD","PSIL","BK4572","IE00B19Z6F94.USD","BBC","BK4588","BK4104","BK4532","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284010","title":"Mirum Advances New Drug Candidate With Fresh Phase 1 Study Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284010","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284010?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305889,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ($MIRM) announced an update on their ongoing clinical study. Mirum Pharmaceuticals, Inc. is running a Phase 1 trial called “A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirum-advances-new-drug-candidate-with-fresh-phase-1-study-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirum-advances-new-drug-candidate-with-fresh-phase-1-study-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284217","title":"10 Friday AM Reads","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284217","media":"The Big Picture","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284217?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:30","pubTimestamp":1784284240,"startTime":"0","endTime":"0","summary":"Wall Street Traders Are Having Their Best Year Ever: JPMorgan, Goldman and other big banks are raking in trading revenue this year as “the market is clearly extremely risk-on.” . From spicy claypot chicken to ‘digitally enabled technology infrastructure player’: Back in 2017, a tiny US-listed drinks company called Long Island Iced Tea suddenly announced that it would henceforth be known as Long Blockchain Company and promptly jumped as much as 500 per cent. It ended pretty much as you’d expect. Even the Nasdaq was shamed into taking action, delisting the company from its exchange. The SEC then got involved, and today the company is no more. Did doubt for even a minute t hat this would end in any other way?!","market":"nz","thumbnail":"https://ritholtz.com/wp-content/uploads/2030/07/retail.png","type":0,"news_type":0,"thumbnails":["https://ritholtz.com/wp-content/uploads/2030/07/retail.png"],"rights":{"source":"ritholtz_highlight","url":"https://ritholtz.com/2026/07/10-friday-am-reads-507/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ritholtz.com/2026/07/10-friday-am-reads-507/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ritholtz_highlight","symbols":["BK4144","AM","BBC","IE00BMQBXF63.USD","IE00BZ18W340.USD","IE00BZ18W456.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172393686","title":"UK Government Enacts Legislation to Nationalize British Steel, Controlled by China's Jingye Group; Chinese Ministry of Commerce Vows Strong Measures to Protect Chinese Firms","url":"https://stock-news.laohu8.com/highlight/detail?id=1172393686","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172393686?lang=en_us&edition=fundamental","pubTime":"2026-07-17 13:52","pubTimestamp":1784267563,"startTime":"0","endTime":"0","summary":"The Chinese Ministry of Commerce has responded to media inquiries regarding the UK government's move to nationalize British Steel.In response to a question about the UK government's announcement on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":129,"code":"91000000","status":"200"}]}}